Clinical Trial Update: The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on heterologous boost strategies using mRNA and protein COVID-19 vaccines in Phase 1 and Phase 2 cohorts for COVID-19 and breakt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Infection

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: COVID-19, Breakthrough Infection | Phase 1, Phase 2 | Status: UNKNOWN